news
Malaria vaccine targets PMIF
A new malaria vaccine targets the protein PMIF, which is crucial in the life cycle of malaria parasites...
List view / Grid view
Malaria
news
CIS43 antibody prevents malaria in mice
Scientists have discovered a human antibody that protected mice from infection with the deadliest malaria parasite, Plasmodium falciparum...
news
CRISPR/Cas9 technique suppresses malaria infection in mosquitos
Genome editing could enable new strategies to prevent malaria transmission to humans...
news
The spreading mechanism of malaria parasites provides new drug target
A team of researchers in the UK have discovered crucial new processes that allow malaria parasites to escape red blood cells and infect other cells, thus offering potential new treatment targets.
news
Five new malaria targets that could lead to an effective vaccine
Scientists have identified five targets that reduce the parasite's ability to invade red blood cells...
news
Optibrium, Imperial College and DNDi to collaborate on drug development
The collaboration will provide MSc students with industry-relevant learning tools and pharma with a new pipeline of candidate compounds.
news
Metabolic markers accurately diagnose typhoid fever
Researchers have identified a metabolite 'signature' that can accurately distinguish typhoid from other fever-inducing tropical diseases using patient blood samples.
news
Novel antibacterial wound cover made from crustaceans
Researchers develop bacteria-fighting wound dressing made with the help of crustaceans…
news
Kymab receives $9m R+D grant from Bill & Melinda Gates Foundation
The monoclonal antibody biopharmaceutical group Kymab announced today that it has received a $9m grant from the Bill & Melinda Gates Foundation to accelerate the development of novel vaccines and therapeutics for infectious diseases, including HIV.
news
Eisai and Charles River announce drug discovery collaboration
15 February 2016 | By Victoria White
Eisai and Charles River have signed a collaboration agreement which will see Charles River scientists work at Eisai’s research and development facilities in Hatfield...
news
£1 billion fund set up to fight malaria and other infectious diseases
23 November 2015 | By Victoria White
The Ross Fund includes £115 million to develop new drugs, diagnostics and insecticides for malaria, TB and other infectious disease resistance...
news
Malaria vaccine provides hope for a cure for cancer
13 October 2015 | By Victoria White
Scientists have created a malaria protein with a toxin seeks out cancer cells. The protein is absorbed, the toxin released inside, and then the cancer cells die...
news
Nobel Prize recognises discoveries in parasitic diseases
5 October 2015 | By Victoria White
The Nobel Prize for Physiology or Medicine has been split this year to recognise work that has revolutionised the treatment of some parasitic diseases...
news
New CRISPR system could change the scientific landscape
28 September 2015 | By Victoria White
The newly described Cpf1 system differs in several important ways from Cas9, with significant implications for research and therapeutics...
news
Takeda joins malaria and TB drug discovery consortium, WIPO Re:Search
14 September 2015 | By Victoria White
WIPO Re:Search provides access to the intellectual property of certain pharmaceutical compounds, technologies, know-how and data for R&D activities around TB and malaria...
